A Multi-Institutional, Prospective, Randomized, Double-blinded, Phase II Trial of the Tumor Lysate, Particle-Only (TLPO) Vaccine Compared to Tumor Lysate, Particle Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in High-risk Melanoma Patients Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chick, RC
  • Faries, MB
  • Hale, DF
  • Bohan, P Kemp
  • Hickerson, AT
  • Vreeland, TJ
  • Myers, JW
  • Cindass, JL
  • Brown, TA
  • Hyngstrom, J
  • Berger, A
  • Jakub, JW
  • Sussman, Jonathan
  • Shaheen, MF
  • Clifton, GT
  • Wagner, TE
  • Peoples, GE

publication date

  • February 2020